ILTS 2012 Report – New Hepatitis C treatments may improve outlook
by Thomas R. Collins – The state of treatment for Hepatitis C patients waiting for a liver transplant leaves a lot to be desired
by Thomas R. Collins – The state of treatment for Hepatitis C patients waiting for a liver transplant leaves a lot to be desired
by Thomas R. Collins – Doing a biopsy on a liver before the organ is procured for transplantation is helpful only when done for certain potential organ donors,
by Thomas R. Collins – With a scarcity of livers available for transplantation, there is a tremendous pressure on the medical community to make the best use of… read more.
by Thomas R. Collins – A living donor liver transplant can be a safe and effective first-line treatment for very young children with biliary atresia,
Dr Irene Scalera, Fellow at the Liver Unit at Queen Elizabeth Hospital, Birmingham, describes the ever-changing donor landscape and attempts to improve liver donor shortage.
Findings from a newly published meta-analysis suggests that levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin users is associated with risk of developing a major cardiovascular event, such… read more.
Paper presented on 5th June at ASCO – by Bruce Sylvester – The antidepressant duloxetine (Cymbalta ®), relieves neuropathic pain caused by chemotherapy in 59 percent of patients,… read more.
by Bruce Sylvester – Researchers from a Phase III study report no difference in rates of viral clearance between two anemia management strategies for patients with chronic hepatitis… read more.
by Bruce Sylvester – Two studies presented at EASL suggest the real human and economic costs of liver disease across Europe.
C. difficile is a bacterium that is common in the environment. According to the Center for Disease Control and Prevention, approximately 337,000 cases of CDI are reported each… read more.
by Bruce Sylvester – Researchers report that combination ABT-450 with ritonavir (ABT-450/r, Abbott) plus ABT-333 plus ribavirin (RBV) is both well tolerated and led to high sustained virological… read more.
Safety results were similar between groups. Data presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tocilizumab monotherapy is more effective than… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.